StockNews.AI
TMCI
StockNews.AI
92 days

Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - TMCI

1. TMCI faces a class action lawsuit for allegedly misleading statements. 2. Competition reportedly hurt demand for TMCI's primary product, Lapiplasty. 3. Company's revenue declined, prompting a need for alternative products. 4. Allegations question the reliability of TMCI's positive business statements. 5. Shareholders encouraged to register for potential class action participation.

5m saved
Insight
Article

FAQ

Why Bearish?

The lawsuit and competition concerns could negatively affect TMCI's stock performance, similar to past cases where companies faced class actions due to misleading statements and revenue declines, which led to stock price drops.

How important is it?

The ongoing class action lawsuit and claims of misleading practices can significantly affect investor sentiment and stock performance, making the article highly relevant to TMCI.

Why Long Term?

The implications of a lawsuit and declining revenue typically impact stock prices over an extended period as the issues are resolved in court and market confidence in the company is reassessed.

Related Companies

NEW YORK, May 19, 2025 /PRNewswire/

The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).

Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=148826&from=4

CLASS PERIOD:

May 8, 2023 to May 7, 2024

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the 3D bunion correction system, the "Lapiplasty"; (2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE:

June 10, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=148826&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of TMCI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is June 10, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm

Related News